Literature DB >> 7909535

Evaluation of a DUR intervention: a case study of histamine antagonists.

D R Zimmerman1, T M Collins, E E Lipowski, F Sainfort.   

Abstract

Drug Utilization Review (DUR) programs aim to control inappropriate prescribing and drug costs, but there are few rigorous studies of their impact. This paper presents the evaluation results of a DUR intervention (excessive duration of full-dose histamine-2 receptor antagonists) using a quasi-experimental design. We observe a greater reduction of H2RA use in the intervention group than in the comparison group, and a reduction in drug expenditures which exceeded the cost of targeting and notifying prescribers. The success of DUR programs depends on both their efficiency and the drug issues under consideration; the use of a comparison group is critical in the evaluation of their impact.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7909535

Source DB:  PubMed          Journal:  Inquiry        ISSN: 0046-9580            Impact factor:   1.730


  7 in total

1.  Changing doctor prescribing behaviour.

Authors:  P S Gill; M Mäkelä; K M Vermeulen; N Freemantle; G Ryan; C Bond; T Thorsen; F M Haaijer-Ruskamp
Journal:  Pharm World Sci       Date:  1999-08

2.  A controlled letter intervention to change prescribing behavior: results of a dual-targeted approach.

Authors:  T M Collins; D A Mott; W E Bigelow; D R Zimmerman
Journal:  Health Serv Res       Date:  1997-10       Impact factor: 3.402

3.  Using feedback letters to influence the use of antiulcer agents in a Medicaid program.

Authors:  D W Raisch; B L Sleath
Journal:  J Gen Intern Med       Date:  1999-03       Impact factor: 5.128

4.  Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations?

Authors:  D M Cromwell; E B Bass; E P Steinberg; Y Yasui; W J Ravich; T R Hendrix; S F McLeod; R D Moore
Journal:  Health Serv Res       Date:  1999-02       Impact factor: 3.402

Review 5.  Comparing the Medicaid Retrospective Drug Utilization Review Program Cost-Savings Methods Used by State Agencies.

Authors:  Sergio I Prada
Journal:  Am Health Drug Benefits       Date:  2017-12

6.  Evaluation results from prospective drug utilization review: Medicaid demonstrations.

Authors:  D Kidder; J Bae
Journal:  Health Care Financ Rev       Date:  1999

7.  Cost-effectiveness and Economic Benefit of Continuous Professional Development for Drug Prescribing: A Systematic Review.

Authors:  David A Cook; Christopher R Stephenson; John M Wilkinson; Stephen Maloney; Jonathan Foo
Journal:  JAMA Netw Open       Date:  2022-01-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.